With the spin-off of Sandoz globally in October, we enter a new era as Novartis. With our new strategy unveiled in 2022, Novartis has now transformed into a focused innovative medicines business, Fran Milnes, president of Novartis Taiwan shares her view toward the New Novartis with Euroview.